Shelf life – Page 5 – Pharma.Tips

Matrixing Misuse in Photostability and Accelerated Studies

Addressing the Challenges of Bracketing and Matrixing Misuse in Stability Studies Bracketing and matrixing are vital techniques used within photostability and accelerated studies for assessing product stability efficiently. However, misuse…

How to Manage Ongoing Stability for Export Market Climatic Zones

Strategies for Addressing Ongoing Stability Program Gaps in Export Markets In the pharmaceutical industry, maintaining product stability is crucial, especially when exporting to varying climatic zones. Ongoing stability program gaps…

Why Bracketing Does Not Replace Stability Study Understanding

Understanding the Limitations of Bracketing and Matrixing in Stability Studies In the pharmaceutical industry, stability studies are critical for ensuring that products maintain their intended quality and efficacy throughout their…

Ongoing Stability Documentation Gaps in Regulatory Audits

Identifying and Resolving Gaps in Ongoing Stability Programs During Regulatory Audits In the pharmaceutical manufacturing landscape, maintaining compliance with ongoing stability programs is crucial, yet many organizations face challenges that…

Reduced Stability Design Mistakes During Post-Approval Changes

Identifying and Addressing Errors in Stability Designs Post-Approval In the dynamic world of pharmaceutical manufacturing, the proper execution of stability studies is critical for regulatory compliance and product safety. Unfortunately,…

How to Integrate Ongoing Stability with Stability Commitment Batches

Enhancing Your Ongoing Stability Program: Addressing Gaps in Stability Commitment Batches In the realm of pharmaceutical manufacturing, maintaining the integrity of drug products over time is critical for regulatory compliance…

How to Handle OOT Results in Bracketing and Matrixing Studies

Addressing Out-of-Trend Results in Bracketing and Matrixing Studies Out-of-Trend (OOT) results in stability studies present significant challenges for pharmaceutical manufacturers. These unexpected outcomes can lead to regulatory scrutiny, product re-evaluations,…

Ongoing Stability Gaps Caused by Poor Chamber Capacity Planning

Tackling Gaps in Stability Programs Due to Ineffective Chamber Capacity Planning Understanding the implications of ongoing stability program gaps is critical for pharmaceutical facilities dedicated to compliance and quality assurance.…

Bracketing Misuse for Different Container Closure Systems

Addressing Misuse of Bracketing in Container Closure Systems Bracketing and matrixing misuse can significantly affect the reliability of stability studies, jeopardizing regulatory compliance and impacting product lifecycle management. This article…

How to Handle OOT Results in Ongoing Stability Programs

Managing Out-of-Trend Results in Your Stability Programs In the fast-paced world of pharmaceutical manufacturing, stability programs play a crucial role in ensuring drug efficacy and safety. However, it is not…

Matrixing Failures Caused by Poor Sample Tracking and Pull Planning

Understanding and Resolving Matrixing Failures Due to Ineffective Sample Tracking and Pull Planning In the realm of pharmaceutical stability studies, bracketing and matrixing serve as essential strategies to optimize resource…

Ongoing Stability Failure Investigation and Batch Impact Assessment

Assessing Batch Impact During Ongoing Stability Investigation Challenges Stability failures in pharmaceutical manufacturing can have significant implications for product quality and regulatory compliance. When stability issues arise, identifying the underlying…